Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) disclosed a repurchase of 60,000 A shares on 10 November 2025, representing approximately 0.0009% of the shares excluding treasury shares prior to the transaction. Following this action, the total number of treasury shares rose from 3,069,010 to 3,129,010.

The number of issued shares excluding treasury shares decreased from 6,375,933,264 to 6,375,873,264, while the overall issued share count remained at 6,379,002,274. The repurchase, conducted on the Shanghai Stock Exchange, was carried out for the A Share Employee Stock Ownership Schemes at a highest price of RMB 61.31 and a lowest price of RMB 61, for a total cost of RMB 3,668,376. Company disclosures confirm compliance with applicable regulatory requirements throughout this process.